Holen Sie sich die Stockscreener-App
10.88
0.18%
0.02
Vorhandelsmarkt:
10.89
0.010
+0.09%
Schlusskurs vom Vortag:
$10.86
Offen:
$10.72
24-Stunden-Volumen:
341.99K
Relative Volume:
0.81
Marktkapitalisierung:
$374.87M
Einnahmen:
$85.23M
Nettoeinkommen (Verlust:
$2.70M
KGV:
173.25
EPS:
0.0628
Netto-Cashflow:
$20.97M
1W Leistung:
+4.11%
1M Leistung:
+19.96%
6M Leistung:
-4.73%
1J Leistung:
-6.45%
1-Tages-Spanne:
$10.61
$11.04
1-Wochen-Bereich:
$10.46
$11.07
52-Wochen-Spanne:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Firmenname
Delcath Systems Inc
Sektor
Branche
Telefon
(518) 743-8892
Adresse
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.88 | 374.18M | 85.23M | 2.70M | 20.97M | 0.0628 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-06-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2022-07-26 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-03-09 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-01-05 | Eingeleitet | BTIG Research | Buy |
| 2020-06-01 | Eingeleitet | Laidlaw | Buy |
Alle ansehen
Delcath Systems Inc Aktie (DCTH) Neueste Nachrichten
JPMorgan Chase & Co. Decreases Position in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems (NASDAQ:DCTH) Stock Price Up 0.3%Time to Buy? - MarketBeat
(DCTH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
DCTH SEC FilingsDelcath Sys 10-K, 10-Q, 8-K Forms - Stock Titan
Risk Off: Can Delcath Systems Inc expand into new markets2026 Fed Impact & Safe Entry Zone Tips - baoquankhu1.vn
Aug Decliners: What are the future prospects of Delcath Systems IncWeekly Investment Report & Weekly High Return Forecasts - baoquankhu1.vn
Implied volatility surging for Delcath Systems stock options - MSN
Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2025 earnings call transcript - MSN
Implied Volatility Soars for Delcath Systems Options - Bitget
Implied Volatility Surging for Delcath Systems Stock Options - TradingView
Is Delcath Systems Inc a strong candidate for buy and holdWeekly Trade Report & Verified Technical Signals - baoquankhu1.vn
Delcath Systems (DCTH) Gains Recognition in Clinical Guidelines - GuruFocus
Delcath therapy included in European uveal melanoma guidelines By Investing.com - Investing.com Australia
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma - BioSpace
Delcath therapy included in European uveal melanoma guidelines - Investing.com
Bear Alert: Is Delcath Systems Inc a strong candidate for buy and holdMarket Weekly Review & Growth Focused Stock Reports - baoquankhu1.vn
Aug Levels: Is Delcath Systems Inc a strong candidate for buy and holdShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
EBIT per share of Delcath Systems, Inc. – MUN:DV3R - TradingView
DCTH PE Ratio & Valuation, Is DCTH Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
DV3R.SG,0P0000X679,0 (DV3R.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Responsive Playbooks and the DCTH Inflection - Stock Traders Daily
Delcath Systems Inc. (US24661P8077.SG) Balance Sheet - Yahoo! Finance Canada
Delcath (NASDAQ: DCTH) seeks approval to expand 2020 equity incentive plan - Stock Titan
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting - BioSpace
DV3R.SG,0P0000X679,0 (DV3R.SG) stock price, news, quote and history - Yahoo Finance UK
Delcath Systems (DCTH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Decliners Report: What are the future prospects of Delcath Systems IncProduct Launch & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Are options traders betting on a big move in Delcath Systems stock? - MSN
Uveal Neoplasms Markets, Companies, and Investment Opportunities Analysis 2026-2030 - GlobeNewswire
Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Q3 2025 Delcath Systems Inc Earnings Call Transcript - GuruFocus
Risk Analysis: Is Delcath Systems Inc backed by strong institutional buyingForecast Cut & Daily Stock Trend Watchlist - baoquankhu1.vn
Market Catalysts: What is BDSXs 5 year growth outlookTrade Analysis Report & Safe Entry Zone Tips - baoquankhu1.vn
Understanding the Setup: (DCTH) and Scalable Risk - Stock Traders Daily
FRA:DV3R PB Ratio: 2.85 — 49% Below Median - GuruFocus
Form 13G DELCATH SYSTEMS For: 20 March By Investing.com - Investing.com Australia
Daniel Kaufman reports 5.08% stake in Delcath Systems (DCTH) - Stock Titan
Divisadero Street Capital Management LP Invests $5.12 Million in Delcath Systems, Inc. $DCTH - MarketBeat
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 from Inve - Yahoo
Finanzdaten der Delcath Systems Inc-Aktie (DCTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):